Potential biomarker emerging for diabetic neuropathy

June 13, 2012
Nervous system

An emerging biomarker may eventually lead to new approaches for treating diabetics at risk of developing nerve damage, UNSW researchers have found.

The researchers say neuropathy in is under-diagnosed and early identification has been problematic. It is estimated that up to 50 per cent of diabetics end up with nerve damage.

They tested excitability in diabetics with and without neuropathy and found those without irreversible still showed excitability abnormalities well before the development of clinical symptoms.

“Excitability testing provides a to identify the early development and severity of diabetic neuropathy,” the key researcher Dr Cindy Lin said.

The research was led by UNSW and the School of Medical Science’s Dr Cindy Lin and is published in the journal Diabetes.

Professor Matthew Kiernan from UNSW says the research may lead to new therapeutic approaches for treating patients with diabetic neuropathy early.

“It may yet prove possible to initiate therapy in diabetic patients well before they manifest the neurological symptoms and disability that inevitably reflects the presence clinical neuropathy,” Professor Kiernan says in his commentary, also published in Diabetes.

“Pharmacological manipulation of axonal membrane channels seems likely to provide further new therapeutic approaches for treating patients with diabetic neuropathy,” he says.

Explore further: To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment

Related Stories

To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment

June 23, 2011
Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in ...

AAN issues new guideline on best treatments for diabetic nerve pain

April 11, 2011
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain, the burning or tingling pain in the hands and feet that affects millions of people with diabetes. The ...

Various metabolic risk factors could be linked to diabetes-related pain with major implications for treatment

May 17, 2012
Around 1 in 50 people in the general population and 1 in 6 of those aged over 40 years experience neuropathy (damage to the nerves of the peripheral nervous system), which can cause numbness, tingling, pain, or weakness. ...

Erectile dysfunction study shows high prevalence of peripheral neuropathy

November 15, 2011
Spanish researchers have uncovered clear links between erectile dysfunction (ED) and peripheral neuropathy, according to a paper in the December issue of the urology journal BJUI.

Diabetes: Tighter control of blood sugar prevents nerve condition, but at what risk?

June 12, 2012
Aggressive control of blood sugar levels in diabetes can help to prevent a painful condition affecting patients' nerves, according to a new systematic review in the Cochrane Library. However, the review suggests that optimal ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.